Skip to main content
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: J Thorac Cardiovasc Surg. 2019 Oct 8;159(4):1626–1635.e1. doi: 10.1016/j.jtcvs.2019.09.123

Table 3.

Demographic characteristics of patients receiving surgery within or after 100 days

<50 days
(n=1174)(%)
50-100 days
(n=950)(%)
> 100 Days
(n=371)(%)
p value
Age (years, median) 64 66 65 0.05
Sex (female) 156(13) 160(17) 54(15) 0.07
Race 0.52
White 1131(98) 914(97) 357(98)
Black 13(1) 14(2) 6(1.5)
Other 14(1) 10(1) 1(0.5)
Year of diagnosis, median (inter-quartile range) 2009(2007-2011) 2010(2008-2012) 2010(2008-2012) <0.001
CDCC Score 0.18
0 808(69) 635(67) 253(68)
1 307(26) 244(26) 91(25)
2+ 59(5) 71(8) 27(7)
Insurance status <0.001
Private 551(48) 367(40) 126(35)
Government 578(51) 538(59) 226(64)
None 11(1) 14(2) 4(1)
Facility location 0.88
Metro 918(82) 750(82) 289(81)
Urban 186(17) 141(16) 59(17)
Rural 20(2) 21(2) 8(2)
Facility type <0.001
Academic/research program 671(58) 614(65) 258(70)
Pathologic stage 0.39
1 818(81) 689(83) 262(83)
2 143(14) 110(13) 41(13)
3 51(5) 28(3) 11(4)
Path N stage 0.91
N0 848(72) 701(74) 278(75)
N1 115(10) 91(10) 32(9)
N2 16(1) 8(1) 4(1)
N3 3(0.3) 6(1) 2(1)
Unknown 192(16) 144(15) 55(15)
Tumor size (median mm with IQR) 17(10-30) 15(7-25) 14(7-25) <0.001
Positive margins 0.12
R0 1097(97) 900(98) 349(97)
R1 19(2) 8(1) 3(1)
R2 1(0.1) 0(0) 2(0.6)
Unspecified positive 13(1) 7(1) 2(0.6)
Indeterminate 6(0.5) 3(0.3) 3(0.8)
Time to surgery (days)(median with IQR) 34(23-42) 69(59-81) 128(112-162) <0.001